Search results
Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
Zacks via Yahoo Finance Canada· 3 days agoEli Lilly (LLY) wins FDA approval for its Alzheimer's disease drug, Kisunla. (donanemab). Sanofi...
EU approves Sanofi drug for chronic lung disease
Medical Xpress· 5 days agoThe European Union has approved Sanofi and Regeneron's blockbuster drug Dupixent for the treatment of chronic obstructive pulmonary disease (COPD), the...
Regeneron (REGN), SNY Win EC Approval for Dupixent for COPD
Zacks via Yahoo Finance Canada· 5 days agoRegeneron (REGN) and partner Sanofi get approval for their blockbuster drug Dupixent for the chronic...
Insider Sale: Director Arthur Ryan Sells Shares of Regeneron Pharmaceuticals Inc (REGN)
GuruFocus.com via Yahoo Finance Canada· 5 days agoThe transaction was documented in an SEC Filing. Following this transaction, the insider now owns...
Insiders At Regeneron Pharmaceuticals Sold US$26m In Stock, Alluding To Potential Weakness
Simply Wall St. via Yahoo Finance Canada· 6 days agoThe fact that multiple Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) insiders offloaded a...
Regeneron (REGN) Gets Positive CHMP Opinion for Lymphoma Drug
Zacks via Yahoo Finance Canada· 7 days agoRegeneron (REGN) gets positive CHMP recommendation for odronextamab for the treatment of adults with...